3.

Univariate and multivariate analysis results for elevated RDW levels in patients with atrial fibrillation with hypertension.

Variable	Univariate analysis				Multivariate analysis
	β	t	P-value		β	t	P-value
ACEIs: angiotensin-converting enzyme inhibitors; AF: atrial fibrillation; ARBs: angiotensin receptor blocking agents; BMI: body mass index; CCBs: calcium channel blockers; DBP: diastolic blood pressure; IVST: interventricular septum thickness; LAD: left atrial diameter; LVEDD: left ventricular end diastolic diameter; LVEF: left ventricular ejection fraction; LVPWT: left ventricular posterior wall thickness; RDW: red cell distribution width; SBP: systolic blood pressure.
Age, yrs	-0.059	-1.095	0.274		-0.018	-0.323	0.747
Male	0.017	0.208	0.745		0.019	0.291	0.772
Smoking	0.095	1.691	0.092		0.087	0.585	0.114
BMI, kg/m2	0.048	0.893	0.373		-0.014	-0.270	0.787
Duration of hypertension, yrs	0.027	0.505	0.614		0.011	0.198	0.843
Office heart rate, beats/min	0.076	1.425	0.155		-0.026	-0.460	0.646
Office SBP, mmHg	0.039	0.728	0.467		0.039	0.739	0.460
Office DBP, mmHg	0.061	1.144	0.253		0.057	1.083	0.280
AF rhythm	0.262	5.061	0.001		0.276	4.448	0.001
Creatinine, μmol/L	-0.062	-1.165	0.245		-0.091	1.443	0.150
LAD, mm	0.134	2.520	0.012		0.106	1.809	0.071
LVEDD, mm	0.041	0.770	0.442		0.011	0.212	0.833
LVEF, %	-0.080	-1.499	0.138		-0.017	-0.312	0.755
IVST, mm	-0.096	-1.802	0.072		-0.094	-1.693	0.091
LVPWT, mm	-0.147	-2.770	0.006		-0.156	-2.778	0.006
Statins	0.108	2.026	0.043		0.065	1.191	0.234
ACEIs/ARBs	0.014	0.263	0.793		-0.005	-0.085	0.933
Beta-blockers	-0.009	-0.165	0.869		-0.043	-0.803	0.423
Diuretics	-0.011	-0.196	0.844		0.039	0.621	0.535
CCBs	-0.065	-1.223	0.222		-0.037	-0.601	-0.548
Aspirin	0.047	0.883	0.378		0.053	0.890	0.374
Anticoagulation drugs	0.004	0.082	0.935		-0.008	-0.137	0.891